Esmolol and Oxymetazoline interaction
Esmolol and Oxymetazoline: both prescribing labels describe an interaction that usually calls for monitoring, a dose change, or spacing the doses.
Usually manageable with monitoring or a dose change. Tell your pharmacist you take both.
What the FDA labels say
From the Esmolol (Brevibloc) label · effective 2026-08-06
Sympathomimetic drugs: Dose adjustment needed (7)
Sympathomimetic drugs: Sympathomimetic drugs having beta-adrenergic agonist activity will counteract effects of BREVIBLOC.
From the Oxymetazoline (UPNEEQ) label · effective 2026-07-23
Caution in using drugs such as beta-blockers, anti-hypertensives, and/or cardiac glycosides is advised.
Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.
Open in the checkerNot medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.